HealthTrust to Offer Nanosphere MDx Tests to Acute Care Facility Members | GenomeWeb

NEW YORK (GenomeWeb) — Nanosphere said today that it has been selected by HealthTrust to provide multi-target molecular diagnostic tests for nearly 1,400 acute care facilities that are part of the HealthTrust membership.

Under the agreement, HealthTrust's members will have access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostics tests for infectious diseases, including assays for detecting infections of the bloodstream, respiratory tract, and gastrointestinal tract.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.